Products
IP Intelligence Reports
Patexia Concierge
Patent Analyzer
Trademarks Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Login
Join
Book a Meeting
Back to All Articles
Browse articles with tag: Inflammatory Disorder
You must be logged in to create a new article
All Articles
Elisabeth Manville
May 9, 2012
New therapeutic target to treat inflammation
Scientists from Queen Mary, University of London have identified tiny organelles called primary cilia as a target for anti-inflammation therapy....
Read More
0 Likes
1 Favorites
0 Comments
Elisabeth Manville
Apr 18, 2012
Potential treatment for inflammatory back pain falls short in study
According to the results of a new study led by Johns Hopkins, a new type of injectable, anti-inflammatory pain medicine...
Read More
0 Likes
0 Favorites
0 Comments
Elisabeth Manville
Mar 19, 2012
New research suggests naturally occurring acid could effectively treat Crohnâs disease
A research team at Virginia Tech has uncovered new information on the efficacy of conjugated linoleic acid (CLA) in treating...
Read More
0 Likes
0 Favorites
0 Comments
Elisabeth Manville
Mar 16, 2012
Psoriasis treatment could also significantly decrease risk of heart attack
A study by the Montreal Heart Institute and Innovaderm Research, Inc., has found that a treatment for psoriasis, a chronic...
Read More
0 Likes
0 Favorites
0 Comments
Leyla Raiani
Feb 23, 2012
Researchers discover how vitamin D inhibits inflammation
In the March 1, 2011, issue of The Journal of Immunology, researchers at the National Jewish Health hospital report the...
Read More
0 Likes
0 Favorites
0 Comments
Alejandro Freixes
Nov 7, 2011
•
Featured
Humira shown to be an effective treatment for non-radiographic axial spondyloarthritis
Abbott announced today, at the American College of Rheumatology Annual Scientific Meeting in Chicago, the results of their Phase-3...
Read More
0 Likes
0 Favorites
0 Comments